BioCentury
ARTICLE | Clinical News

Avonex interferon beta-1a: Postmarketing study data

July 23, 2012 7:00 AM UTC

The study included patients with RRMS from the British Columbia MS database. The treated cohort comprised patients exposed to interferon beta who first became eligible for treatment between July 1995 ...